Clinical utility may be greatest with careful patient selection, given frailty-associated toxicity and potential endpoint inflation in indolent tumors, warranting larger validation cohorts and ...
Treatment Intensification With Either Fludarabine, AraC, G-CSF and Idarubicin, or Cladribine Plus Daunorubicin and AraC on the Basis of Residual Disease Status in Older Patients With AML: Results From ...
This study showed that some variants in GNAS (encoding the Gα s protein) cause childhood obesity. Subsequent findings indicate the broad clinical variability of a monogenic disease and have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results